-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...
More »SEARCH RESULT
Total Matching Records found : 1343
What other farmers can learn from Manipur's Devakanta -Manu AB
-Rediff.com Potshangbam Devakanta from Manipur shows the way in conserving the biodiversity of the state, farming around 100 traditional varieties of paddy and rare medicinal plants, finds Manu A B/Rediff.com. When farmers across India are grappling with weather woes and poor yields, Potshangbam Devakanta from Manipur has succeeded in adopting smart and eco-friendly methods of farming to ensure his harvest is satisfactory year after year. Like thousands of farmers in India, 60-year-old Devakanta...
More »Dr Imrana Qadeer, public health scholar and professor at the Centre of Social Medicine and Community Health (JNU), speaks to Poornima Joshi
-The Hindu Business Line How the Indian State metamorphosed from protector of the poor to facilitator of the private health industry If there is correlation between two incidents of the Central Government announcing cuts in the health budget and dengue Patients being refused treatment in Delhi’s private hospitals, it is rarely discussed in the ongoing media debate on the subject. A new collection of researched essays edited by public health scholar Imrana...
More »Scientifically validated Rs 5 anti-diabetes herbal drug launched by CSIR -Neha Shukla
-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...
More »When Hospitals Infect -Gauri Kamath
-The Indian Express Indian healthcare providers need to get serious about infection control. A deadly strain of bacterium has doubled its resistance to last-resort antibiotics within a year, according to the report “State of the World’s Antibiotics, 2015”. By an estimate, antimicrobial resistance — the ability of bugs to outwit antibiotics — will claim two million lives in India by 2050, a fifth of the total. India is under pressure to curb...
More »
